PubMed Health⌕ Search

Biomedical subjects

Makio Ishiguro

Publications and source records attributed to Makio Ishiguro.

2 recordsLinked to original sources

Extended information criterion (EIC) approach for linear mixed effects models under restricted maximum likelihood (REML) estimation.

In clinical data analysis, the restricted maximum likelihood (REML) method has been commonly used for estimating variance components in the linear mixed effects model. Under the REML estimation, however, it is not straightforward to compare several linear mixed effects models with different mean and covariance structures. In particular, few approaches have been proposed for the comparison of linear mixed effects models with different mean structures under the REML estimation. We propose an approach using extended information criterion (EIC), which is a bootstrap-based extension of AIC, for comparing linear mixed effects models with different mean and covariance structures under the REML estimation. We present simulation studies and applications to two actual clinical data sets.

Biometry↗

A simulation-based confidence band for drug concentrations in blood: an application to a clinical phase I trial.

Since drug concentrations in blood are usually related to the effectiveness and toxicity, a confidence band for the drug concentrations gives useful information for the treatment. This paper proposes a simulation-based approach for constructing confidence bands for drug concentrations in blood. The confidence band covers the whole profile of the drug concentrations with a specified probability. The proposed approach presupposes that actual concentrations of a subject fluctuate randomly around a curve specified by an appropriate pharmacokinetic model and the subject-specific pharmacokinetic parameters. The confidence band is constructed by taking into account both the random fluctuations of the actual concentrations and the statistical uncertainty of the parameter estimates. The proposed approach is applied to a simulation study and an actual phase I trial.

Clinical Trials, Phase I as Topic↗